May 8, 2019
Eisai and its US partner Purdue Pharma have ended their collaboration for the worldwide development and promotion of the Japanese company’s investigational sleep-wake regulation agent lemborexant (development code: E2006), they said on April 30. Eisai will now solely develop and...read more